WBA - Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook Takes $5.8B Impairment Charge Related To VillageMD Business | Benzinga
Walgreens Boots Alliance Inc’s (NASDAQ: WBA) second quarter fiscal year 2024 sales increased 6.3% Y/Y to $37.1 billion, up 5.7% on a constant currency basis, beating the consensus of $35.86 billion.
Adjusted operating income was $900 million, a decrease of 26.5% on a constant currency basis, reflecting lower sale-leaseback gains and softer U.S. retail performance, partly offset by improved profitability in the U.S. Healthcare segment.
Adjusted EPS increased 3.4% to $1.20, up 2.8% on a constant currency basis, reflecting a lower adjusted effective tax rate and improved profitability in U.S. Healthcare, beating ...